<DOC>
	<DOCNO>NCT00972777</DOCNO>
	<brief_summary>This study conduct evaluate clinical microbial efficacy besifloxacin ophthalmic suspension compare vehicle treatment bacterial conjunctivitis . This study conduct phase IIb study continue enrollment phase III study .</brief_summary>
	<brief_title>Efficacy Besifloxacin Ophthalmic Suspension Treatment Bacterial Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Bacterial</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>7- ( 3-aminohexahydro-1H-azepin-1-yl ) -8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid</mesh_term>
	<criteria>Subjects least one year age . Subjects clinical diagnosis acute bacterial conjunctivitis . Subjects willing discontinue contact lens wear duration study . Subjects uncontrolled systemic disease debilitate disease . Subjects known sensitivity contraindication besifloxacin , fluoroquinolones ingredient study drug . Subjects expect require treatment disallow medication .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>